Subthreshold micropulse laser treatment for autosomal recessive bestrophinopathy complicated by macular neovascularization

Abstract

Purpose

To present a case of autosomal recessive bestrophinopathy (ARB) complicated by intraretinal fluid and subretinal fluid, successfully managed with navigated subthreshold micropulse laser (SML) treatment.

Obervations

A 25-year-old female was referred to our clinic by her ophthalmologist due to a diagnosis of reduced vision in both eyes. The patient presented with a visual acuity of 0.9 logMAR in both eyes. Structural optical coherence tomography (OCT) revealed bilateral intraretinal fluid (IRF) and subretinal fluid (SRF), while OCT angiography (OCT-A) demonstrated bilateral macular neovascularization (MNV). Following the initiation of intravitreal therapy with anti-VEGF agents, administered via monthly injections for one year, we observed no improvement in visual acuity or resolution of IRF and SRF. SML treatment was administered to both eyes in the macular region. At the 3-month follow-up visit, OCT revealed complete resolution of IRF in the right eye and partial resolution of IRF in the left eye, and best-corrected visual acuity (BCVA) improved from 0.9 logMAR to 0.7 logMAR.

Conclusions and importance

In our case, SML emerges as a promising treatment modality for patients with ARB complicated by MNV who exhibit poor response to anti-VEGF therapy. However, further prospective studies with longer follow-up periods and larger cohorts are warranted to confirm the optimal treatment strategy in ARB.

Keywords

Best retinopathy best vitelliform macular dystrophy OCT OCTA subthreshold micropluse laser

Get full access to this article

View all access options for this article.

References

Petrukhin

Koisti

Bakall

, et al. Identification of the gene responsible for Best macular dystrophy. Nat Genet 1998; 19: 241–247.

Marmorstein

Rayborn

, et al. Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci 2000; 97: 12758–12763.

Boon

CJF

Klevering

Leroy

, et al. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res 2009; 28: 187–205.

Burgess

Millar

Leroy

, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 2008; 82: 19–31.

Boon

CJF

Van Den Born

Visser

, et al. Autosomal recessive bestrophinopathy. Ophthalmology 2013; 120: 809–820.

Iannaccone

. Autosomal recessive Best vitelliform macular dystrophy: report of a family and management of early-onset neovascular complications. Arch Ophthalmol 2011; 129: 211.

Luttrull

Margolis

BWL

. Functionally guided retinal protective therapy for dry age-related macular and inherited retinal degenerations: a pilot study. Investig Opthalmology Vis Sci 2016; 57: 265.

Casalino

Khan

Armengol

, et al. Autosomal recessive bestrophinopathy. Ophthalmology 2021; 128: 706–718.

Pfister

Zein

Cukras

, et al. Phenotypic and genetic Spectrum of autosomal recessive bestrophinopathy and Best vitelliform macular dystrophy. Investig Opthalmology Vis Sci 2021; 62: 22.

10.

Scholz

Altay

Fauser

. A review of subthreshold micropulse Laser for treatment of macular disorders. Adv Ther 2017; 34: 1528–1555.